Search

August 11, 2011 (Aurora, CO)–In an article published online this week in Nature Genetics, a University of Colorado Cancer Center team in partnership with universities in China and Denmark. Recognizing the genetic mutations that make bladder cancer cells different than their healthy neighbors may allow early genetic screenings for cancer...

Newswise — July 25, 2011 (Philadelphia, PA) –Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors. Scientists...

A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin’s lymphoma are most likely to develop radiation-induced second cancers years after treatment. Knowing in advance who is at risk could help physicians tailor treatment to...

The progress in viral vector manufacturing and gene editing means orthopedic specialists may soon be able to offer treatments that genuinely restore cartilage, not just mask symptoms. Ongoing developments focus on increasing the specificity of gene delivery, enhancing the durability of therapeutic effects, and scaling up production methods to allow widespread clinical adoption.

Longevity science is a proactive approach to the universal problem of disease and aging. It no longer makes sense to wait until someone is old and grey to spend tons of money managing a disease that could’ve been avoided altogether. Instead, longevity experts recommend lifestyle changes and scientific interventions to prevent the onset of the disease in the first place.

MedicalResearch.com Interview with: Christopher Choi, PhD, MBA Senior Vice President of Industry Partnerships Associate Professor of Oncology Technical Director of GMP Engineering & Cell Manufacturing Roswell Park Comprehensive Cancer Center Buffalo, NY MedicalResearch.com: What is the background for this study?  What is a GMP facility? Response: The opening of the...

MedicalResearch.com Interview with: Dr. J Joseph Melenhorst, PhD Director, Product Development & Correlative Sciences laboratories (PDCS) Adjunct Associate Professor Penn Medicine Center for Cellular Immunotherapies University of Pennsylvania MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by CLL and CAR T cells?  Response: We...

MedicalResearch.com Interview with: Dr. W. Stephen Brimijoin PhD Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic, Rochester, MN 55905 MedicalResearch.com: What is the background for this study? What are the main findings? Response: The background for this study was: 1) Ordinary C57 black mice readily become obese when given unrestricted access...

MedicalResearch.com Interview with: Dr. Emerson C. Perin MD, PhD Texas Heart Institute Medical Director, BSLMC Catheterization Laboratory Director, Research in Cardiovascular Medicine Medical Director, Stem Cell Center  MedicalResearch.com: What is the background for this study? Dr. Perin: Critical limb ischemia (CLI) is a devastating and debilitating disease characterized by reduced...

MedicalResearch.com Interview with: David B. Weiner, Ph.D. Professor, Department of Pathology and Laboratory Medicine Chair, Gene Therapy and Vaccine Program, CAMB Co-Leader Tumor Virology Program, Abramson Cancer Program University of Pennsylvania, Perelman School of Medicine Medical Research: What is the background for this study? What are the main findings? Dr. Weiner:...

MedicalResearch.com Interview with: Erwin G. Van Meir, PhD Professor, Departments of Neurosurgery and Hematology & Medical Oncology Leader, Winship Cancer Institute Cancer Cell Biology Program Founding Director, Graduate Program in Cancer Biology Director, Laboratory for Molecular Neuro-Oncology Emory University School of Medicine Atlanta GA 30322 Medical Research: What is the background...

MedicalResearch.com Interview with: Dr. John A Kessler MD The Ken and Ruth Davee Professor of Stem Cell Biology Department of Neurology Professor, Department of Pharmacology Northwestern University Feinberg School of Medicine Medical Research: What is the background for this study? What are the main findings? Dr. Kessler: Painful diabetic neuropathy...

MedicalResearch.com Interview with: Mine Tezal, DDS, PhD Oral Biology University at Buffalo NYS Center of Excellence in Bioinformatics and Life Sciences MedicalResearch.com: What are the main findings of the study?   Dr. Tezal: We observed an inverse association between dental caries and head and neck cancer (HNSCC), which persisted among...

MedicalResearch.com Interview with Dr. Boelens Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands MedicalResearch.com: What are the main findings of the study? Dr. Boelens: For children with Hurler’s syndrome, the receipt of a hematopoietic cell transplant (HCT) early in life with the best available human leukocyte...